Matter Neuroscience, a NYC-based company providing people with personalized insights into their brain chemistry, raised $26m in funding.
The round consisted in an initial seeded by Polaris Partners and a more recent round co-led by ARCH Venture Partners, Polaris Partners, and Exor Ventures, and joined by Collaborative Fund and others.
The company intends to use the funds to bolster its efforts to continue to develop its solutions.
Founded in 2019 by Axel Bouchon and Ben Goldhirsh with Chris Shiflett joining in 2021 as co-founder, Matter Neuroscience leverages neuroscience to provide solutions to help people improve their health and happiness. The company has released an early version of its public beta app for users and plans to further develop the technology it has used in clinical studies through the help of public usage of the app. The app is designed to provide individuals with a tool to record and reflect on their positive experiences, to better understand the neurotransmitter activity behind them, and to make changes in their daily lives. Matter also offers users access to educational materials and a lecture series on the neuroscience of happiness.
FinSMEs
01/03/2024